Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yasuhiko Yamanaka

Managing Director of Special Missions and Director, Takeda Pharmaceutical Company Limited
AgeTotal Calculated CompensationThis person is connected to 18 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Mr. Yasuhiko Yamanaka has been Managing Director of Special Missions of Takeda Pharmaceutical Company Limited since June 2014 and served as its Managing Director since June 2011. Mr. Yamanaka has been a Managing Director at Takeda Pharmaceuticals International, Inc. since June 24, 2011 and Assistant To Chief Executive Officer since April 1, 2012. Mr. Yamanaka served as Senior Vice President of Pharmaceutical Marketing Division and General Manager of Pharmaceutical Marketing ...

Read Full Background

Corporate Headquarters*

1-1, Doshomachi 4-chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

2007-Present
Managing Director of Special Missions and Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥5,059.00 JPY +58.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$985.0K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Haruo Naito Chief Executive Officer, Representative Corporate Officer and Director
Eisai Co., Ltd.
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.